Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Fesnak

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA|April 14, 2011
Conceptualizing physician professionalismAndrew Fesnak, Vijay Rajput
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2019
Place of Academic GMP Facilities in Modern Cell TherapyAlexey Bersenev, Andrew Fesnak
Transfusion Medicine Reviews|April 13, 2016
CAR-T Cell Therapies From the Transfusion Medicine PerspectiveAndrew Fesnak, ChieYu Lin, Don L Siegel, et al.
Transfusion|December 23, 2025
Training in cell and gene therapy manufacturing: Unmet needs and arguments for graduate medical educationYongping Wang, David McKenna, Thomas Spitzer, et al.
Transfusion|February 10, 2022
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?Indira Guleria, Maria de Los Angeles Muñiz, Matthew Wilgo, et al.
The Journal of Clinical Investigation|November 17, 2021
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumoniaKatharine J Bar, Pamela A Shaw, Grace H Choi, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA|April 14, 2011
Conceptualizing physician professionalismAndrew Fesnak, Vijay Rajput
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2019
Place of Academic GMP Facilities in Modern Cell TherapyAlexey Bersenev, Andrew Fesnak
Transfusion Medicine Reviews|April 13, 2016
CAR-T Cell Therapies From the Transfusion Medicine PerspectiveAndrew Fesnak, ChieYu Lin, Don L Siegel, et al.
Transfusion|December 23, 2025
Training in cell and gene therapy manufacturing: Unmet needs and arguments for graduate medical educationYongping Wang, David McKenna, Thomas Spitzer, et al.
Transfusion|February 10, 2022
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?Indira Guleria, Maria de Los Angeles Muñiz, Matthew Wilgo, et al.
The Journal of Clinical Investigation|November 17, 2021
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumoniaKatharine J Bar, Pamela A Shaw, Grace H Choi, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Pageof 1